Skip to main content
Premium Trial:

Request an Annual Quote

Inproteo Licenses Patent to Genentech

NEW YORK, Jan. 21 (GenomeWeb News) - Inproteo, formerly known as the Indiana Proteomics Consortium, announced today that it has licensed US Patent No. 4,569,794 to Genentech.


The deal covers a patent, and its foreign counterparts, that describes a fusion protein purification technique known commonly as "His Tag."


The license covers all uses of the technology for the life of the patents, Inproteo said in a statement. Financial details were not disclosed.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.